FOLH1 and medullary thyroid gland carcinoma: PSMA expression was also reported in two cases of medullary thyroid carcinoma (MTC) [55, 56], a condition generally challenging to treat: the use of [177Lu]Lu-DOTATATE-PRRT is only feasible in MTC presenting high SSTR (which is not common).